Alis-HCT 300:25 Tablet Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Alis-HCT 300:25 Tablet.

Available Products of Alis-HCT 300:25 Tablet

Alis-HCT 300:25 Tablet 10

Reg#: 067817

Description of Alis-HCT 300:25 Tablet

Aliskirin (as hemifumarate)+ Hydrochlorthiazide 300 mg+ 25 mg

Medicine Info

Pack Size: 10

Company: HIGHNOON LABORATORIES LIMITED

Price of Alis-HCT 300:25 Tablet

Price: Rs. 1871.22

Related Keywords

  • Alis-HCT 300:25 Tablet price in Pakistan
  • Alis-HCT 300:25 Tablet tablet price
  • Alis-HCT 300:25 Tablet Capsule price
  • HIGHNOON LABORATORIES LIMITED Alis-HCT 300:25 Tablet price
  • Buy Alis-HCT 300:25 Tablet online
  • Alis-HCT 300:25 Tablet uses
  • Alis-HCT 300:25 Tablet syrup price
  • Alis-HCT 300:25 Tablet pack 10 cost

Alis-HCT 300:25 Tablet 14

Reg#: 067817

Description of Alis-HCT 300:25 Tablet

Aliskirin (as hemifumarate)+ Hydrochlorthiazide 300 mg+ 25 mg

Medicine Info

Pack Size: 14

Company: HIGHNOON LABORATORIES LIMITED

Price of Alis-HCT 300:25 Tablet

Price: Rs. 2618.33

Related Keywords

  • Alis-HCT 300:25 Tablet price in Pakistan
  • Alis-HCT 300:25 Tablet tablet price
  • Alis-HCT 300:25 Tablet Capsule price
  • HIGHNOON LABORATORIES LIMITED Alis-HCT 300:25 Tablet price
  • Buy Alis-HCT 300:25 Tablet online
  • Alis-HCT 300:25 Tablet uses
  • Alis-HCT 300:25 Tablet syrup price
  • Alis-HCT 300:25 Tablet pack 14 cost

Alternatives brands of Alis-HCT 300:25 Tablet

Explore alternative brands for Alis-HCT 300:25 Tablet below.

View Alternatives

Explore More Medicines

Alkyloxan Tablets 50 mg

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 599.9266

Amonate Tablet 100:270

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 130.9448

Amonate Tablet 25:67.5

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 23.5029

Amonate Tablet 50:135

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 38.6119

Apomen Tablets 125 mg

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 538.8150

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!